H.R. 2004: Tyler’s Law
This bill, known as Tyler’s Law, aims to address the potential incorporation of fentanyl testing in hospital emergency departments for patients experiencing an overdose. The key components of the bill include:
Study Requirements
The Secretary of Health and Human Services (HHS) is required to conduct a study within one year of the bill's enactment. This study will focus on several aspects:
- How often emergency departments currently test for fentanyl alongside other substances like amphetamines, cocaine, opiates, and marijuana during overdose situations.
- The costs associated with fentanyl testing.
- The potential benefits and risks of such testing for patients.
- How fentanyl testing might influence the patient's experience in terms of privacy and the patient-physician relationship.
Guidance Issuance
Following the completion of the study, HHS must issue guidance within six months. This guidance will cover:
- Whether fentanyl testing should be instituted as a standard procedure for overdose cases in emergency departments.
- How hospitals can inform clinicians about the substances being tested for in standard drug tests, irrespective of whether fentanyl is included.
- The potential effects of fentanyl testing on the future risk of overdose and overall health outcomes for patients.
Definition of Hospital Emergency Department
For the purposes of this bill, a "hospital emergency department" is defined according to existing legal standards found in the Social Security Act.
Relevant Companies
- PHM - This company, which operates healthcare facilities, may be affected by changes in testing protocols for substance use and the potential increase in testing costs.
- AMGN - As a biopharmaceutical company involved in treatment solutions for substance abuse, changes in guidelines may impact their market strategies.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
61 bill sponsors
-
TrackTed Lieu
Sponsor
-
TrackMark Alford
Co-Sponsor
-
TrackDon Bacon
Co-Sponsor
-
TrackTroy Balderson
Co-Sponsor
-
TrackNanette Diaz Barragán
Co-Sponsor
-
TrackGus M. Bilirakis
Co-Sponsor
-
TrackRobert Bresnahan
Co-Sponsor
-
TrackNikki Budzinski
Co-Sponsor
-
TrackSheila Cherfilus-McCormick
Co-Sponsor
-
TrackJuan Ciscomani
Co-Sponsor
-
TrackAngie Craig
Co-Sponsor
-
TrackDan Crenshaw
Co-Sponsor
-
TrackSharice Davids
Co-Sponsor
-
TrackMonica De La Cruz
Co-Sponsor
-
TrackMadeleine Dean
Co-Sponsor
-
TrackDebbie Dingell
Co-Sponsor
-
TrackNeal P. Dunn
Co-Sponsor
-
TrackGabe Evans
Co-Sponsor
-
TrackRandy Fine
Co-Sponsor
-
TrackBrian K. Fitzpatrick
Co-Sponsor
-
TrackRussell Fry
Co-Sponsor
-
TrackJosh Gottheimer
Co-Sponsor
-
TrackRaúl M. Grijalva
Co-Sponsor
-
TrackChrissy Houlahan
Co-Sponsor
-
TrackSydney Kamlager-Dove
Co-Sponsor
-
TrackRobin L. Kelly
Co-Sponsor
-
TrackTimothy M. Kennedy
Co-Sponsor
-
TrackYoung Kim
Co-Sponsor
-
TrackRaja Krishnamoorthi
Co-Sponsor
-
TrackGreg Landsman
Co-Sponsor
-
TrackRobert E. Latta
Co-Sponsor
-
TrackMichael Lawler
Co-Sponsor
-
TrackRyan Mackenzie
Co-Sponsor
-
TrackSarah McBride
Co-Sponsor
-
TrackJennifer L. McClellan
Co-Sponsor
-
TrackRobert Menendez
Co-Sponsor
-
TrackCarol D. Miller
Co-Sponsor
-
TrackMariannette Miller-Meeks
Co-Sponsor
-
TrackCory Mills
Co-Sponsor
-
TrackEleanor Holmes Norton
Co-Sponsor
-
TrackZachary Nunn
Co-Sponsor
-
TrackJay Obernolte
Co-Sponsor
-
TrackAlexandria Ocasio-Cortez
Co-Sponsor
-
TrackChris Pappas
Co-Sponsor
-
TrackScott H. Peters
Co-Sponsor
-
TrackAugust Pfluger
Co-Sponsor
-
TrackRaul Ruiz
Co-Sponsor
-
TrackJohn H. Rutherford
Co-Sponsor
-
TrackJanice D. Schakowsky
Co-Sponsor
-
TrackKim Schrier
Co-Sponsor
-
TrackDarren Soto
Co-Sponsor
-
TrackThomas R. Suozzi
Co-Sponsor
-
TrackDina Titus
Co-Sponsor
-
TrackPaul Tonko
Co-Sponsor
-
TrackLori Trahan
Co-Sponsor
-
TrackDavid G. Valadao
Co-Sponsor
-
TrackGabe Vasquez
Co-Sponsor
-
TrackMarc A. Veasey
Co-Sponsor
-
TrackDebbie Wasserman Schultz
Co-Sponsor
-
TrackRandy K. Weber, Sr.
Co-Sponsor
-
TrackRudy Yakym III
Co-Sponsor
Actions
5 actions
| Date | Action |
|---|---|
| Jun. 25, 2026 | Forwarded by Subcommittee to Full Committee by Voice Vote. |
| Jun. 25, 2026 | Subcommittee Consideration and Mark-up Session Held |
| Mar. 10, 2025 | Introduced in House |
| Mar. 10, 2025 | Referred to the House Committee on Energy and Commerce. |
| Mar. 10, 2025 | Referred to the Subcommittee on Health. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
